2026 NPPES data Addiction Medicine (Psychiatry & Neurology) Physician NPI 1538190541 M.D.
Verify on CMS →

SUNIL RANGWANI, M.D.

Addiction Medicine (Psychiatry & Neurology) Physician in ALMA, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 292 beneficiaries · Addiction Medicine (Psychiatry & Neurology) Physician avg: 1K
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$380.88
4 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SUNIL RANGWANI, M.D. reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 3,844 Medicare Part D claims in 2023.

100/100
MIPS score · +17 vs avg
4K
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SUNIL RANGWANI, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 7% higher than 93% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

SUNIL RANGWANI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SUNIL RANGWANI, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 07/06/2006

NPI 1538190541

Primary specialty

Addiction Medicine (Psychiatry & Neurology) Physician

Niche

658 US NPIs in this specialty

Medicare Part D claims

3,844 277% vs specialty avg

2023 prescription claims

Specialty avg: 1,019

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Michigan

How Addiction Medicine (Psychiatry & Neurology) Physician compares to other specialties among Michigan providers

Michigan providers

Addiction Medicine (Psychiatry & Neurology) Physician share within Michigan

1. Addiction Medicine (Psychiatry & Neurology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Addiction Medicine (Psychiatry & Neurology) Physician share within Michigan

Medicare quality performance — MIPS

SUNIL RANGWANI, M.D.'s 2023 MIPS final score plotted against the Addiction Medicine (Psychiatry & Neurology) Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Addiction Medicine (Psychiatry & Neurology) Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Addiction Medicine (Psychiatry & Neurology) Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SUNIL RANGWANI, M.D. appears in the CMS NPPES registry as a Addiction Medicine (Psychiatry & Neurology) Physician provider holding M.D. credentials at 317 E WARWICK DR, ALMA, MI, 48801, with a listed phone of (989) 463-2779. NPI 1538190541 was issued on 07/06/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RANGWANI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,844 prescription claims written by this provider, covering 292 Medicare beneficiaries and totaling roughly $695K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 76.436, Cost 100), compared with the national average of 83.1.

Addiction Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 658 enrolled providers across 49 states and an average of 1,019 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

317 E WARWICK DR
ALMA, MI 48801

Provider Details

NPI 1538190541
Specialty Addiction Medicine (Psychiatry & Neurology) Physician
Credentials M.D.
Gender Male
NPI Issued 07/06/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
76.436
Quality
100
Cost
97
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where SUNIL RANGWANI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

FAMILY HEALTH PSYCHIATRIC AND COUNSELING CENTER, PC
ALMA, MI
GRATIOT INTEGRATED HEALTH NETWORK
ALMA, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SUNIL RANGWANI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$381

Largest payer

Janssen Pharmaceuticals, Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to SUNIL RANGWANI, M.D.. To verify SUNIL RANGWANI, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,844
Total Claims
$695K
Total Drug Cost
292
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,292
Total Day Supply
120,776
Generic Drug Cost
$137K

Patient Demographics

Average Patient Age
61.8 years
Avg HCC Risk Score
1.38
Gender Split
55% female / 45% male
Age Distribution
<65: 138, 65-74: 90, 75-84: 48, 85+: 16

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SUNIL RANGWANI, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Quetiapine Fumarate
358
Olanzapine
302
Trazodone Hcl
235
Duloxetine Hcl
172
Sertraline Hcl
172
Fluoxetine Hcl
136
Mirtazapine
136
Risperidone
132
Benztropine Mesylate
129
Buspirone Hcl
129

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction Medicine (Psychiatry & Neurology) Physician Overview

How SUNIL RANGWANI, M.D. fits within the Addiction Medicine (Psychiatry & Neurology) Physician landscape nationally.

658
Addiction Medicine (Psychiatry & Neurology) Physician Providers in US
49
States with Addiction Medicine (Psychiatry & Neurology) Physician
1,019
Avg Claims per Provider

SUNIL RANGWANI, M.D.'s 3,844 claims are above the specialty average of 1,019.

Nearby Addiction Medicine (Psychiatry & Neurology) Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as RANGWANI.

Compare Addiction Medicine (Psychiatry & Neurology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SUNIL RANGWANI, M.D.'s specialty?
SUNIL RANGWANI, M.D. specializes in Addiction Medicine (Psychiatry & Neurology) Physician and practices in ALMA, Michigan. Credentials: M.D..
How much does SUNIL RANGWANI, M.D. prescribe under Medicare Part D?
In 2023, SUNIL RANGWANI, M.D. wrote 3,844 Medicare Part D claims totaling $695K in drug costs for 292 beneficiaries.
What is SUNIL RANGWANI, M.D.'s Medicare quality score?
SUNIL RANGWANI, M.D. has a CMS MIPS Final Score of 100/100 (Quality: 76.436, Cost: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SUNIL RANGWANI, M.D. located?
SUNIL RANGWANI, M.D. is located at 317 E WARWICK DR, ALMA, MI, 48801. Phone: (989) 463-2779.
What is SUNIL RANGWANI, M.D.'s NPI number?
SUNIL RANGWANI, M.D.'s National Provider Identifier (NPI) is 1538190541, issued on 07/06/2006.
How many Addiction Medicine (Psychiatry & Neurology) Physician providers are there in the US?
There are 658 Addiction Medicine (Psychiatry & Neurology) Physician providers across 49 states in the US. The average Addiction Medicine (Psychiatry & Neurology) Physician provider writes 1,019 Medicare Part D claims per year.
What drugs does SUNIL RANGWANI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SUNIL RANGWANI, M.D.'s most frequently prescribed drugs include Quetiapine Fumarate, Olanzapine, Trazodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SUNIL RANGWANI, M.D. accept Medicare?
SUNIL RANGWANI, M.D. appears in CMS Medicare data with 3,844 Part D claims and 292 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SUNIL RANGWANI, M.D.'s credentials?
SUNIL RANGWANI, M.D.'s NPI is 1538190541 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology